221 related articles for article (PubMed ID: 32879200)
1. Exploratory Research on the Relationship between Human Gut Microbiota and Portal Hypertension.
Yokoyama K; Tsuchiya N; Yamauchi R; Miyayama T; Uchida Y; Shibata K; Fukuda H; Umeda K; Takata K; Tanaka T; Inomata S; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
Intern Med; 2020; 59(17):2089-2094. PubMed ID: 32879200
[TBL] [Abstract][Full Text] [Related]
2. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg.
Arab JP; Martin-Mateos RM; Shah VH
Hepatol Int; 2018 Feb; 12(Suppl 1):24-33. PubMed ID: 28550391
[TBL] [Abstract][Full Text] [Related]
3. Effects of the adjunctive probiotic VSL#3 on portal haemodynamics in patients with cirrhosis and large varices: a randomized trial.
Gupta N; Kumar A; Sharma P; Garg V; Sharma BC; Sarin SK
Liver Int; 2013 Sep; 33(8):1148-57. PubMed ID: 23601333
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota-related complications in cirrhosis.
Gómez-Hurtado I; Such J; Sanz Y; Francés R
World J Gastroenterol; 2014 Nov; 20(42):15624-31. PubMed ID: 25400446
[TBL] [Abstract][Full Text] [Related]
5. Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis.
Wu Z; Zhou H; Liu D; Deng F
Front Cell Infect Microbiol; 2023; 13():1218552. PubMed ID: 37483387
[TBL] [Abstract][Full Text] [Related]
6. [Disorders of gut microflora in the pathogenesis of liver cirrhosis and complications of portal hypertension].
Anikina EV; Kovtun AV; Iakovenko AV; Gioeva IZ; Iakovenko ÉP; Agafonova NA; Ivanov AN; Volosheĭnikova TV; Grigor'eva IuV
Eksp Klin Gastroenterol; 2014; (12):20-3. PubMed ID: 26058107
[TBL] [Abstract][Full Text] [Related]
7. Potential mechanisms linking gut microbiota and portal hypertension.
Baffy G
Liver Int; 2019 Apr; 39(4):598-609. PubMed ID: 30312513
[TBL] [Abstract][Full Text] [Related]
8. Breaking bad - the two sides of gut microbiota in portal hypertension.
Mehta G; Mookerjee RP
Liver Int; 2014 Oct; 34(9):1295-7. PubMed ID: 24840789
[No Abstract] [Full Text] [Related]
9. von Willebrand factor as a novel noninvasive predictor of portal hypertension and esophageal varices in hepatitis B patients with cirrhosis.
Wu H; Yan S; Wang G; Cui S; Zhang C; Zhu Q
Scand J Gastroenterol; 2015; 50(9):1160-9. PubMed ID: 25877661
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota and host metabolism in liver cirrhosis.
Usami M; Miyoshi M; Yamashita H
World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
[TBL] [Abstract][Full Text] [Related]
11. Circulating microbiome in patients with portal hypertension.
Gedgaudas R; Bajaj JS; Skieceviciene J; Varkalaite G; Jurkeviciute G; Gelman S; Valantiene I; Zykus R; Pranculis A; Bang C; Franke A; Schramm C; Kupcinskas J
Gut Microbes; 2022; 14(1):2029674. PubMed ID: 35130114
[TBL] [Abstract][Full Text] [Related]
12. Gut microbiota profile in healthy Indonesians.
Rahayu ES; Utami T; Mariyatun M; Hasan PN; Kamil RZ; Setyawan RH; Pamungkaningtyas FH; Harahap IA; Wiryohanjoyo DV; Pramesi PC; Cahyanto MN; Sujaya IN; Juffrie M
World J Gastroenterol; 2019 Mar; 25(12):1478-1491. PubMed ID: 30948911
[TBL] [Abstract][Full Text] [Related]
13. Maternal diet during pregnancy is related with the infant stool microbiome in a delivery mode-dependent manner.
Lundgren SN; Madan JC; Emond JA; Morrison HG; Christensen BC; Karagas MR; Hoen AG
Microbiome; 2018 Jul; 6(1):109. PubMed ID: 29973274
[TBL] [Abstract][Full Text] [Related]
14. Microbiome and bacterial translocation in cirrhosis.
Gómez-Hurtado I; Such J; Francés R
Gastroenterol Hepatol; 2016 Dec; 39(10):687-696. PubMed ID: 26775042
[TBL] [Abstract][Full Text] [Related]
15. Changes in the Intestinal Microbiome during a Multispecies Probiotic Intervention in Compensated Cirrhosis.
Horvath A; Durdevic M; Leber B; di Vora K; Rainer F; Krones E; Douschan P; Spindelboeck W; Durchschein F; Zollner G; Stauber RE; Fickert P; Stiegler P; Stadlbauer V
Nutrients; 2020 Jun; 12(6):. PubMed ID: 32585997
[TBL] [Abstract][Full Text] [Related]
16. Small intestinal motility disturbances and bacterial overgrowth in patients with liver cirrhosis and portal hypertension.
Gunnarsdottir SA; Sadik R; Shev S; Simrén M; Sjövall H; Stotzer PO; Abrahamsson H; Olsson R; Björnsson ES
Am J Gastroenterol; 2003 Jun; 98(6):1362-70. PubMed ID: 12818282
[TBL] [Abstract][Full Text] [Related]
17. Phylogenetic analysis of the human gut microbiota using 16S rDNA clone libraries and strictly anaerobic culture-based methods.
Hayashi H; Sakamoto M; Benno Y
Microbiol Immunol; 2002; 46(8):535-48. PubMed ID: 12363017
[TBL] [Abstract][Full Text] [Related]
18. Probiotics in Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis, and Cirrhosis.
Qamar AA
J Clin Gastroenterol; 2015; 49 Suppl 1():S28-32. PubMed ID: 26447961
[TBL] [Abstract][Full Text] [Related]
19. Advances in the treatment of portal hypertension in cirrhosis.
Kimer N; Wiese S; Mo S; Møller S; Bendtsen F
Expert Rev Gastroenterol Hepatol; 2016 Aug; 10(8):961-9. PubMed ID: 26982499
[TBL] [Abstract][Full Text] [Related]
20. Ascitic microbiota composition is correlated with clinical severity in cirrhosis with portal hypertension.
Rogers GB; van der Gast CJ; Bruce KD; Marsh P; Collins JE; Sutton J; Wright M
PLoS One; 2013; 8(9):e74884. PubMed ID: 24086392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
